Course on Antiplatelet Agents in the Perioperative Period

About this course

Released: 02/01/2011
Expires: 02/01/2014

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES


ACCREDITATION STATEMENT

The International Anesthesia Research Society designates each Journal-Based CME activity (article) for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The IARS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Anesthesia & Analgesia, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The International Anesthesia Research Society designates each CME activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The International Anesthesia Research Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

COMMERCIAL SUPPORT

This CME program is supported entirely by the International Anesthesia Research Society. There is no commercial sponsorship of this program.

EDUCATIONAL OBJECTIVE

After completing this course, participants will be able to appropriately manage patients who are taking antiplatelet agents in the perioperative period.

DISCLOSURES

Jeffrey B. Gross, M.D., Editor, Anesthesia & Analgesia CME Program and Steven L. Shafer, M.D., Editor-in-Chief of Anesthesia & Analgesia, report that they have no financial relationships or interests to disclose relative to the content of the CME program.

Authors
Richard Hall has previously received honoraria from Bayer, Easai, and Eli Lilly (makers of pharmaceutical agents referred to in this paper).
C. David Mazer has previously received honoraria from Bayer, Astra Zeneca and Bristol Myers Squibb (makers of pharmaceutical agents referred to in this paper).